Free Newsletter
Billionaire puts brains, bucks behind supercomputer
Billionaire computer scientist David E. Shaw is leading a project to develop a powerful new supercomputer that could undertake work on protein folding and other advanced biomedical simulation projects. Dubbed Anton, the supercomputer is equipped with 512 specialized processors that all work simultaneously. And as the New York Times notes in its article, that computing power could be put to work folding proteins into 3-D structures, examining the interplay of proteins or the way proteins and new drugs interact.
This kind of computer simulation could play a key role in identifying new therapeutics with a very high likelihood of success--one of the Holy Grails in biomedical research, where so many projects end up in failure.
- read the article in the New York Times
Related Articles:
Artificial DNA molecule offers powerful new biotech tool
Professor creates virtual in vivo cancer environment
Can gamers beat the protein chemistry challenge?
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
